The United States Patent and Trademark Office (USPTO) has published patent application US20260085094A1, titled 'Stapled Peptide and Use Thereof'. The application, filed on November 8, 2022, by inventors Zhixiang PAN, Haiying HE, Zhigan JIANG, and Shuhui CHEN, describes a series of stapled peptides and their therapeutic applications. Specifically, it covers polypeptides with sequences defined by formulas (I-1)-(I-5) and (II-6), along with their pharmaceutically acceptable salts.

This publication represents a new patent application and does not impose immediate compliance obligations. However, it signifies potential future intellectual property rights related to novel peptide therapeutics. Companies involved in drug discovery and development, particularly in areas utilizing peptide-based treatments, should be aware of this filing as it may impact their research and development strategies or patent landscape. No compliance deadlines or penalties are associated with this patent application publication itself.